Genetic Engineering Publications - GEG Tech top picks
36.6K views | +0 today
Follow
Genetic Engineering Publications - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

Human ESC–derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration

Human ESC–derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
Empty description
BigField GEG Tech's insight:
Human ESC–derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration
No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells

Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here the authors used the CRISPR system to precisely repair in patient-specific iPSCs an RPGR point mutation that causes X-linked retinitis pigmentosa (XLRP). They observed that 13% of RPGR gene copies showed mutation correction and conversion to the wild-type allele. This important proof-of-concept finding supports the development of personalized iPSC-based transplantation therapies for retinal disease.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Personalized therapeutic strategies for patients with retinitis pigmentosa

Personalized therapeutic strategies for patients with retinitis pigmentosa | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:
This review discusses the wide-ranging applications of iPSCs and CRISPR with an ultimate view towards understanding how these two technologies can come together to address disease heterogeneity and orphan genes in a novel personalized medicine platform. An extensive literature search was conducted in PubMed and Google Scholar, with a particular focus on high-impact research published within the last 1 – 2 years and centered broadly on the subjects of retinal gene therapy, iPSC-derived outer retina cells, stem cell transplantation and CRISPR/Cas gene editing.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration - Nature

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration - Nature | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this work, the devise a homology-independent targeted integration (HITI) strategy, which allows for robust DNA knock-in in both dividing and non-dividing cells in vitro and, more importantly, in vivo (for example, in neurons of postnatal mammals). As a proof of concept of its therapeutic potential, they demonstrate the efficacy of HITI in improving visual function using a rat model of the retinal degeneration condition retinitis pigmentosa. The HITI method presented here establishes new avenues for basic research and targeted gene therapies.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Human iPSC derived disease model of MERTK-associated retinitis pigmentosa -

Human iPSC derived disease model of MERTK-associated retinitis pigmentosa - | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this study, the authors report successful generation of human induced pluripotent stem cells (iPSC) from skin fibroblasts of a patient harboring a novel Ser331Cysfs*5 mutation in the MERTK gene. Upon differentiation of these iPSC towards RPE, patient-specific RPE cells exhibited defective phagocytosis, a characteristic phenotype of MERTK deficiency observed in human patients and animal models. 

This cellular model allows to investigate in detail the disease mechanism, explore screening of a variety of therapeutic compounds/reagents and design either combined cell and gene- based therapies or independent approaches.


www.geg-tech.com/Vectors

No comment yet.